Finance

Lists
Why is PMN down 3.02%?
Dive Deeper
PMN:NASDAQ
Promis Neurosciences Inc
US$3.21
-3.02%
(-0.100) 1D
US$3.15
-1.87% (-0.060)
After hours
Closed: ኖቬም 17, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMN...
Open
US$3.12
High
US$3.39
Low
US$3.10
Mkt. cap
28.88 ሚ
Avg. vol.
293.11 ሺ
Volume
145.51 ሺ
52-wk high
US$27.40
52-wk low
US$2.78
EPS
-US$12.61
Beta
-0.15
Shares outstanding
9.00 ሚ
No. of employees
11
Open
US$3.12
High
US$3.39
Low
US$3.10
Mkt. cap
28.88 ሚ
Avg. vol.
293.11 ሺ
Volume
145.51 ሺ
52-wk high
US$27.40
52-wk low
US$2.78
EPS
-US$12.61
Beta
-0.15
Shares outstanding
9.00 ሚ
No. of employees
11
News stories
From web sources and news partners
About Promis Neurosciences Inc
CEO-
Employees11
Founded2005
Headquartersሚሲሳጋኦ, ኦንቴሪዮ, ካናዳ
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to PMN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PMN in the last 3 months.
Highest
Current US$3.21
US$100.00 (+3,015.26%)
Average
US$44.33 (+1,281.00%)
Lowest
US$15.00 (+367.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$15.00
+367.3%
11/13/2026
Eddie Hickman
Guggenheim
Buy
Reiterated
US$100.00
+3,015.3%
11/13/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$18.00
+460.7%
11/09/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$35.00
+990.3%
08/14/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$33.00
+928%
08/13/2026
Unknown Analyst
Guggenheim
Buy
Maintained
US$35.00
+990.3%
07/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
US$39.75
+1,138.3%
06/29/2026
Unknown Analyst
Brookline Capital Markets
Buy
Initiated
US$40.00
+1,146.1%
05/20/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
-
-
-
-
Cost of goods sold
9.37 ሚ
-
9.52 ሚ
-
Cost of revenue
9.37 ሚ
-
9.52 ሚ
-
Research and development expenses
-
6.97 ሚ
-
6.71 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.40 ሚ
1.67 ሚ
2.74 ሚ
1.91 ሚ
Operating expense
1.40 ሚ
8.64 ሚ
2.74 ሚ
8.62 ሚ
Total operating expenses
10.77 ሚ
8.64 ሚ
12.27 ሚ
8.62 ሚ
Operating income
-10.77 ሚ
-8.64 ሚ
-12.27 ሚ
-8.62 ሚ
Other non operating income
98.03 ሺ
400.52 ሺ
536.74 ሺ
453.56 ሺ
EBT including unusual items
-10.67 ሚ
-8.24 ሚ
-11.73 ሚ
-8.16 ሚ
EBT excluding unusual items
-10.67 ሚ
-8.24 ሚ
-11.73 ሚ
-8.16 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.67 ሚ
-8.24 ሚ
-11.73 ሚ
-8.16 ሚ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች